Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 4 | 6 |
| List of Tables | 7 | 1 |
| List of Figures | 8 | 2 |
| Introduction | 10 | 1 |
| GBI Report Coverage | 10 | 1 |
| Americas API Market | 11 | 33 |
| Americas API Industry Structure | 11 | 1 |
| Americas API Industry Challenges | 12 | 1 |
| Economic Downturn has Restricted Investment in Pharmaceutical Industry | 12 | 1 |
| High Costs Hinder New Drug Development in the Region | 12 | 1 |
| Maturity of Synthetic APIs Hamper Profit Margin Growth | 12 | 1 |
| Regulatory Changes Lead to Delays in the Launch of New Drugs in the Market | 12 | 1 |
| Patent Expiries of Best Selling Drugs Threatens Revenue Growth | 12 | 1 |
| Americas API Industry Trends | 12 | 1 |
| Patent Expiries are Changing Pharmaceutical Market Dynamics in America | 12 | 1 |
| Specialty Driven Products are Expected to Play an Important Role in the American API Market | 12 | 1 |
| Outsourcing of API Manufacturing is Growing Fast in America | 13 | 1 |
| Mergers and Acquisitions (M&A) Activities have Increased Significantly in the American Pharmaceutical Industry | 13 | 1 |
| Americas API Market Revenue Analysis and Forecasts to 2016 | 14 | 2 |
| Americas API Market Revenue Share Analysis by Product Type and Forecasts to 2016 | 16 | 1 |
| Americas API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecast to 2016 | 17 | 1 |
| Americas API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecast to 2016 | 18 | 1 |
| Americas API Market Revenue Share Analysis by Country and Forecasts to 2016 | 19 | 1 |
| North America API Market | 20 | 1 |
| North America API Market Overview | 20 | 1 |
| North America API Market Drivers | 20 | 1 |
| Continuous Growth in the Pharmaceutical Industry Sustains the API Market s Growth in North America | 20 | 1 |
| Generic Sector Spurs the Growth of the API Market of the Region | 20 | 1 |
| Increasing Focus on Biological Drugs Helps the API Market s Revenue Growth | 20 | 1 |
| North America API Market Restraints | 20 | 1 |
| Recent Economic Slowdown has Restricted the Growth of the Pharmaceutical Industry | 20 | 1 |
| High Cost Involved in New Drug Development Hampers Innovation | 20 | 1 |
| Patent Expiries of Blockbuster Molecules will Contain the Growth of the API Market in North America | 21 | 1 |
| North America API Market Revenue Analysis and Forecasts to 2016 | 22 | 2 |
| North America API Market Revenue Share Analysis by Product Type and Forecasts to 2016 | 24 | 1 |
| North America API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecast to 2016 | 24 | 3 |
| North America API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecast to 2016 | 27 | 3 |
| North America API Market Revenue Share Analysis by Country and Forecasts to 2016 | 30 | 1 |
| North America API Market Competitive Landscape | 31 | 2 |
| South and Central America API Market | 33 | 1 |
| South and Central America API Market Overview | 33 | 1 |
| South and Central America API Market Drivers | 33 | 1 |
| Growing Demand for Pharmaceuticals in the Region is the Major Force Behind API Market Growth | 33 | 1 |
| Improvement in Regulatory Environment | 33 | 1 |
| Government Support and Growing Investments in the Pharmaceutical Industry Gives a Boost to API Market Growth | 33 | 1 |
| Increasing Number of Clinical Trials Leading to Market Growth | 33 | 1 |
| Ageing Population and Increasing Prevalence of Lifestyle Diseases Fuel Market Growth | 33 | 1 |
| South and Central America API Market Restraints | 34 | 1 |
| Import Dependence for API Restricts Market Growth | 34 | 1 |
| Delay in Regulatory Processes Hinders the Industry Growth | 34 | 1 |
| South and Central America API Market Revenue Analysis and Forecasts to 2016 | 34 | 2 |
| South and Central America API Market Revenue Share Analysis by Product Type and Forecasts to 2016 | 36 | 1 |
| South and Central America API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecast to 2016 | 36 | 3 |
| South and Central America API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecast to 2016 | 39 | 3 |
| South and Central America API Market Revenue Share Analysis by Country and Forecasts to 2016 | 42 | 1 |
| South and Central America API Market Competitive Landscape | 43 | 1 |
| The US API Market | 44 | 12 |
| The US API Market Overview | 44 | 1 |
| The US API Market Drivers | 44 | 1 |
| The Rising Incidence of Lifestyle and Old Age Diseases is Giving Rise to API Demand in the Region | 44 | 1 |
| Growth in Oncology is One of the Major Contributing Factors to the Growth of APIs in the Region | 44 | 1 |
| Growth in Biotechnology will Favor Growth of API Market Revenues | 44 | 1 |
| Increasing Focus on High Potency APIs Helps Market Growth | 44 | 1 |
| The US API Market Restraints | 44 | 1 |
| The Economic Downturn has Restricted the Growth of API Demand in the US | 44 | 1 |
| Decreasing Focus on the Innovator Sector Limits the Growth of the US API Market | 45 | 1 |
| Patent Expiry of Some Blockbuster Molecules Will Adversely Affect the Growth of the API Market in the Region | 45 | 1 |
| Rising Competition from China and India is Creating Price Pressure in the US Market | 45 | 1 |
| The US API Market Revenue Analysis and Forecasts to 2016 | 45 | 2 |
| The US API Market Revenue Share Analysis by Product Type and Forecasts to 2016 | 47 | 1 |
| The US API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2016 | 47 | 3 |
| The US API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2016 | 50 | 3 |
| The US API Market Revenue Share Analysis by Therapeutic Category | 53 | 1 |
| The US API Market SWOT Analysis | 54 | 1 |
| Strengths | 54 | 1 |
| World s Largest Pharmaceutical Market | 54 | 1 |
| Increased Focus on Innovation | 54 | 1 |
| Weaknesses | 54 | 1 |
| Maturity of the Market | 54 | 1 |
| Large Number of Patent Expiries | 54 | 1 |
| Opportunities | 55 | 1 |
| Growing Market for Generics | 55 | 1 |
| Growth in Biotechnology | 55 | 1 |
| Increased Coverage of Insurance | 55 | 1 |
| Threats | 55 | 1 |
| Increasing Competition from Generics | 55 | 1 |
| Rising R&D Costs | 55 | 1 |
| Tighter Regulations | 55 | 1 |
| Canada API Market | 56 | 11 |
| Canada API Market Overview | 56 | 1 |
| Canada API Market Drivers | 56 | 1 |
| Government Support for Increasing Healthcare Standards Encourages API Market Growth | 56 | 1 |
| Fast Growing Biotechnology Industry in the Country Increases Demand for APIs | 56 | 1 |
| Growth in Old Age Population in Canada Provides Leads to Growth of the API Market | 56 | 1 |
| Canada API Market Restraints | 56 | 1 |
| Patent Expiries of Some Blockbuster Drugs Will Negatively Impact the API Market | 56 | 1 |
| Price Controls by the Government Affects API Market Revenues | 56 | 1 |
| Canada API Market Revenue Analysis and Forecasts to 2016 | 57 | 1 |
| Canada API Market Revenue Share Analysis by Product Type and Forecasts to 2016 | 58 | 1 |
| Canada API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2016 | 58 | 3 |
| Canada API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2016 | 61 | 3 |
| Canada API Market Revenue Share Analysis by Therapeutic Category | 64 | 1 |
| Canada API Market SWOT Analysis | 65 | 1 |
| Strengths | 65 | 1 |
| Government Support | 65 | 1 |
| Large Biotechnology Industry | 65 | 1 |
| Weaknesses | 65 | 1 |
| Large Number of Drug Patent Expiries | 65 | 1 |
| Government Drug Price Controls | 65 | 1 |
| Opportunities | 66 | 1 |
| Ageing Population | 66 | 1 |
| Increasing Demand for Generic Drugs | 66 | 1 |
| Growing Export Market | 66 | 1 |
| Threats | 66 | 1 |
| Drug Price Decline | 66 | 1 |
| Mexico API Market | 67 | 11 |
| Mexico API Market Overview | 67 | 1 |
| Mexico API Market Drivers | 67 | 1 |
| Strong Growth in Pharmaceutical Market Leads the API Market in Mexico | 67 | 1 |
| Rapid Growth in Generics Market Encouraging API Demand | 67 | 1 |
| Mexico API Market Restraints | 67 | 1 |
| Patent Expiries of Blockbuster Drugs will Negatively Impact Market Revenue Growth | 67 | 1 |
| The Problem of Counterfeits Challenging the Market | 67 | 1 |
| Mexico API Market Revenue Analysis and Forecasts to 2016 | 68 | 1 |
| Mexico API Market Revenue Share Analysis by Product Type and Forecasts to 2016 | 69 | 1 |
| Mexico API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2016 | 69 | 3 |
| Mexico API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2016 | 72 | 3 |
| Mexico API Market Revenue Share Analysis by Therapeutic Category | 75 | 1 |
| Mexico API Market SWOT Analysis | 76 | 1 |
| Strengths | 76 | 1 |
| Pharmaceutical Market Growth | 76 | 1 |
| Relatively Stronger Patent Protection | 76 | 1 |
| Weaknesses | 76 | 1 |
| Patent Expiries | 76 | 1 |
| Counterfeits | 77 | 1 |
| Opportunities | 77 | 1 |
| Fast Growing Generic Drugs Market | 77 | 1 |
| Threats | 77 | 1 |
| Restrictions on Healthcare Expenditure | 77 | 1 |
| Brazil API Market | 78 | 11 |
| Brazil API Market Overview | 78 | 1 |
| Brazil API Market Drivers | 78 | 1 |
| Strongly Growing Economy Gives Boost to the API Market | 78 | 1 |
| Increase in Old Age Population Gives Rise to APIs Demand | 78 | 1 |
| Rapidly Growing Demand for Generic Drugs will Drive the Country s API Market | 78 | 1 |
| Brazil API Market Restraints | 78 | 1 |
| Delay in Drug Approvals Hinders the Market Growth | 78 | 1 |
| The Dependency on Imports for Pharmaceutical Raw Materials Restricts Market Growth | 78 | 1 |
| Brazil API Market Revenue Analysis and Forecasts to 2016 | 79 | 1 |
| Brazil API Market Revenue Share Analysis by Product Type and Forecasts to 2016 | 80 | 1 |
| Brazil API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2016 | 80 | 3 |
| Brazil API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2016 | 83 | 3 |
| Brazil API Market Revenue Share Analysis by Therapeutic Category | 86 | 1 |
| Brazil API Market SWOT Analysis | 87 | 1 |
| Strengths | 87 | 1 |
| Strong Economic Growth | 87 | 1 |
| Large Generics Market | 87 | 1 |
| Government Support to Healthcare Investments | 87 | 1 |
| Weaknesses | 88 | 1 |
| Limited Infrastructure and Technical Capabilities | 88 | 1 |
| Reliance on Imports | 88 | 1 |
| Weaker IP Protection System | 88 | 1 |
| Opportunities | 88 | 1 |
| Rapid Growth in Healthcare Industry | 88 | 1 |
| Ageing Population | 88 | 1 |
| Threats | 88 | 1 |
| Government Support Favoring Public Sector | 88 | 1 |
| Price Fluctuations | 88 | 1 |
| Appendix | 89 | 3 |
| Abbreviations | 89 | 1 |
| Methodology | 89 | 2 |
| Coverage | 89 | 1 |
| Secondary Research | 90 | 1 |
| Primary Research | 90 | 1 |
| Expert Panel Validation | 90 | 1 |
| Contact Us | 90 | 1 |
| About GBI Research | 91 | 1 |
| Disclaimer | 91 | 1 |